Koru Medical price target raised to $6.25 from $6 at Craig-Hallum

Craig-Hallum raised the firm’s price target on Koru Medical (KRMD) to $6.25 from $6 and keeps a Buy rating on the shares following Koru’s strong quarter, as international growth continues to inflect and the core U.S. SCIg business delivers above-market performance. Overall, revenue grew 27% year-over-year, surpassing expectations, and guidance was raised.